Editorial Commentary.

Abstract

No AccessUrology PracticeHealth Policy1 May 2022Editorial CommentaryThis article comments on the following:Appropriateness Criteria for Ureteral Stent Omission following Ureteroscopy for Urinary Stone Disease Jonathan Rubenstein Jonathan RubensteinJonathan Rubenstein Chair, Coding and Reimbursement Committee, American Urological Association, Compliance Officer, Medical Director of Coding and Reimbursement, United Urology Group and Chesapeake Urology Associates, Towson, Maryland More articles by this author View All Author Informationhttps://doi.org/10.1097/UPJ.0000000000000302.01AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Editorial Commentary." Urology Practice, 9(3), p. 263 © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesUrology PracticeMar 3, 2022, 12:00:00 AMAppropriateness Criteria for Ureteral Stent Omission following Ureteroscopy for Urinary Stone Disease Volume 9Issue 3May 2022Page: 263-263 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jonathan Rubenstein Chair, Coding and Reimbursement Committee, American Urological Association, Compliance Officer, Medical Director of Coding and Reimbursement, United Urology Group and Chesapeake Urology Associates, Towson, Maryland More articles by this author Expand All Advertisement PDF DownloadLoading ...